Safinamide and Tramadol Interaction

Drug interaction information between Safinamide and Tramadol.

Safinamide and Tramadol have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Safinamide and Tramadol. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Safinamide

MAO-B Inhibitor

Drug B

Tramadol

Opioid Analgesic

How They Interact

Combining these drugs can cause a dangerous buildup of serotonin in the brain, which may lead to a life-threatening reaction.

FDA Label Information

7.2 Opioid Drugs Because serious, sometimes fatal reactions have been precipitated with concomitant use of opioid drugs (e.g., meperidine and its derivatives, methadone, propoxyphene, or tramadol) and MAOIs, including selective MAO-B inhibitors, concomitant use of these drugs is contraindicated [see Warnings and Precautions (5.2) ] .

Frequently Asked Questions

What SPL severity band is on file for Safinamide + Tramadol?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Tramadol has 38 labeled pairs on file vs Safinamide's 10. In the major band specifically: Safinamide has 6 (also Methylphenidate, Linezolid, Methadone, Meperidine); Tramadol has 1.

What mechanism field is on file for Safinamide and Tramadol?

Combining these drugs can cause a dangerous buildup of serotonin in the brain, which may lead to a life-threatening reaction.

Safinamide carries more major-labeled pairs than Tramadol

SPL source-record counts only. This page's band is major · classes on file: Safinamide (MAO-B Inhibitor); Tramadol (Opioid Analgesic).

Safinamide has 6 major-labeled pairs vs Tramadol's 1.

Safinamide

6 major · 0 moderate · 4 minor · 10 total

Tramadol

1 major · 3 moderate · 34 minor · 38 total

Tramadol has no other major-band peer in this dataset besides Safinamide.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.